May 10, 2018 - By Ellis Scott

Medigene AG (OTCMKTS:MDGEF) Logo

The stock of MEDIGENE AG ORDINARY SHARES (OTCMKTS:MDGEF) registered an increase of 2.58% in short interest. MDGEF’s total short interest was 91,400 shares in May as published by FINRA. Its up 2.58% from 89,100 shares, reported previously. With 400 shares average volume, it will take short sellers 229 days to cover their MDGEF’s short positions. The short interest to MEDIGENE AG ORDINARY SHARES’s float is 0.47%.

It closed at $17.1 lastly. It is down 0.00% since May 10, 2017 and is . It has underperformed by 11.55% the S&P500.

Medigene AG, a biotechnology company, develops immunotherapy platforms to treat a range of cancers in various stages. The company has market cap of $368.45 million. It operates through two divisions, Immunotherapies and Other Products. It currently has negative earnings. The firm develops Dendritic cell vaccines in phase I/II clinical trials; and T-cell receptor-modified T cells and T-cell-specific monoclonal antibodies in preclinical development phase.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.